These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30954310)

  • 21. [Study on the Effects of Ginsenoside Rb1 on DPPC Bilayers by Using Thermo-Raman Spectrum and DSC].
    Hui G; Liu W; Zhang JZ; Zhou TL; Wang SM; Zhao Y; Zhao B
    Guang Pu Xue Yu Guang Pu Fen Xi; 2015 Aug; 35(8):2176-9. PubMed ID: 26672288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
    Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
    J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 May; 101():786. PubMed ID: 29525673
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].
    Akagi EM; de Sá Júnior PL; Simons SM; Bellini MH; Barreto SA; Chudzinski-Tavassi AM
    Biomed Pharmacother; 2019 Oct; 118():109108. PubMed ID: 31235339
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "GJ-4 alleviates Aβ
    Zhang Z; Liu H; Zhao Z; Zang C; Ju C; Li F; Wang L; Yang H; Bao X; Yu Y; Yao X; Zhang D
    Biomed Pharmacother; 2020 Aug; 128():110335. PubMed ID: 32505384
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Luteolin, a flavonoid, as an anticancer agent: A review" [Biomed. Pharmacother. 112 (2019) 108612].
    Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Erdogan Orhan I; Rizwan M; Atif M; Aslam Gondal T; Mubarak MS
    Biomed Pharmacother; 2019 Aug; 116():109084. PubMed ID: 31178263
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice.
    Hao K; Gong P; Sun SQ; Hao HP; Wang GJ; Dai Y; Liang Y; Xie L; Li FY
    Eur J Pharmacol; 2011 May; 659(1):15-25. PubMed ID: 21414307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.
    Lee HU; Bae EA; Han MJ; Kim NJ; Kim DH
    Liver Int; 2005 Oct; 25(5):1069-73. PubMed ID: 16162168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetic screening of multiple components of the Nao Mai Tong formula in rat plasma by liquid chromatography tandem mass spectrometry combined with pattern recognition method and its application to comparative pharmacokinetics.
    Wu C; Zhao L; Rong Y; Zhu G; Liang S; Wang S
    J Pharm Biomed Anal; 2016 Nov; 131():345-354. PubMed ID: 27632784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032].
    Weng MC; Li MH; Chung JG; Liu YC; Jeng-Yuan W; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Oct; 118():109209. PubMed ID: 31324388
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor" [Biomed. Pharmacother. 90 (2017) 914-920].
    Zhang H; Yan X; Wang DG; Leng YF; Wan ZH; Liu YQ; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1569. PubMed ID: 29153378
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review" [Biomed. Pharmacother. 92 (2017) 681-689].
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Shams-Ul-Hassan S
    Biomed Pharmacother; 2018 May; 101():820. PubMed ID: 29525678
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Nucleosome binding peptide presents laudable biophysical and in vivo effects" [Biomed. Pharmacother. 121 (2020) 109678].
    Teles K; Fernandes V; Silva I; Leite M; Grisolia C; Lobbia VR; van Ingen H; Honorato R; Lopes-de-Oliveira P; Treptow W; Santos G
    Biomed Pharmacother; 2020 Mar; 123():109805. PubMed ID: 31956008
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Co-encapsulation of dual drug loaded in MLNPs: Implication on sustained drug release and effectively inducing apoptosis in oral carcinoma cells" [Biomed. Pharmacother. 104 (2018) 661-671].
    Sivaraj M; Mukherjee A; Mariappan R; Govindhan A; Murugaraj J
    Biomed Pharmacother; 2020 May; 125():109969. PubMed ID: 32088023
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair.
    Kawahira K; Sumiyoshi M; Sakanaka M; Kimura Y
    J Ethnopharmacol; 2008 May; 117(2):278-84. PubMed ID: 18329832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2018 Mar; 99():1033-1036. PubMed ID: 29398246
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB" [Biomed. Pharmacother. 108 (2018) 316-324].
    Yuchen S; Jizhao W; Shupei P; Tian Y; Xuanzi S; Ya W; Xiaobo S; Xu Z; Jing G; Xiaozhi Z
    Biomed Pharmacother; 2019 Mar; 111():1507. PubMed ID: 30600121
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" [Biomed. Pharmacother. 93(2017):444-450].
    Li D; Liu J; Wei D; Liu H; Xiao W; Song X; Fan Z; Ke C; Qiangguo Y; Qin W; Tang Y; Xiaoyong P
    Biomed Pharmacother; 2018 Aug; 104():854. PubMed ID: 29753602
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Exosomes: An emerging factor in atherosclerosis" [Biomed. Pharmacother. 115 (2019) 108951].
    Wang Y; Xie Y; Zhang A; Wang M; Fang Z; Zhang J
    Biomed Pharmacother; 2019 Oct; 118():109119. PubMed ID: 31230947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.